Calcineurin inhibition by polaprezinc in rats with experimentally-induced colitis

Life Sciences

Volumn 88, Issue 9-10, 2011, Pages 432-439

  Zhang, Yajing ^a   Okamura, Shinichi ^a   Kudo, Tomohiro ^a   Masuo, Takashige ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Calcineurin; Colitis; Immunosuppressive agents; NFATC transcription factors; Polaprezinc; Zinc

Indexed keywords

CALCINEURIN; CYCLOSPORIN; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; POLAPREZINC; TACROLIMUS; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL VIABILITY; COLITIS; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME INHIBITION; EXPERIMENTALLY INDUCED COLITIS; IN VITRO STUDY; LEUKEMIA CELL LINE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION;

ADMINISTRATION, RECTAL; ANIMALS; ANTI-ULCER AGENTS; CALCINEURIN; CARNOSINE; CELL SURVIVAL; COLITIS; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HUMANS; INTERLEUKIN-2; INTESTINAL MUCOSA; JURKAT CELLS; MALE; NFATC TRANSCRIPTION FACTORS; ORGANOMETALLIC COMPOUNDS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TRINITROBENZENESULFONIC ACID; ZINC COMPOUNDS;

RATTUS; RATTUS NORVEGICUS;

EID: 79951950622     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.12.018     Document Type: Article

References (38)

1. Brynskov J, Freund L, Rasmussen SN, Lauritsen K, de Muckadell OS, Williams N, et al. A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med 1989;321:845-50. (Pubitemid 19238615)
2. Buchholz M, Schatz A, Wagner M, Michl P, Linhart T, Adler G, et al. Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway. EMBO J 2006;25:3714-24. (Pubitemid 44264881)
3. Cho CH, Luk CT, Ogle CW. The membrane-stabilizing action of zinc carnosine (Z-103) in stress-induced gastric ulceration in rats. Life Sci 1991;49:189-94.
4. de la Rosa M, Rutz S, Dorninger H, Scheffold A. Interleukin-2 is essential for CD4+CD25 + regulatory T cell function. Eur J Immunol 2004;34:2480-8. (Pubitemid 39302805)
5. Dianda L, Hanby AM, Wright NA, Sebesteny A, Hayday AC, Owen MJ. T cell receptoralpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol 1997;150:91-7. (Pubitemid 27027100)
6. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995;109:1344-67.
7. Hsieh SY, Shih TC, Yeh CY, Lin CJ, Chou YY, Lee YS. Comparative proteomic studies on the pathogenesis of human ulcerative colitis. Proteomics 2006;6:5322-31.
8. Ishiguro K, Ando T, Maeda O, Ohmiya N, Niwa Y, Goto H. Acetate inhibits NFAT activation in T cells via importin beta1 interference. Eur J Immunol 2007;37:2309-16. (Pubitemid 47250222)
9. Kamradt T, Mitchison NA. Tolerance and autoimmunity. N Engl J Med 2001;344:655-64. (Pubitemid 32183582)
10. Kiani A, Rao A, Aramburu J. Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity 2000;12:359-72.
11. King MM, Huang CY. Activation of calcineurin by nickel ions. Biochem Biophys Res Commun 1983;114:955-61.
12. Lakshmikuttyamma A, Selvakumar P, Kanthan R, Kanthan SC, Sharma RK. Increased expression of calcineurin in human colorectal adenocarcinomas. J Cell Biochem 2005;95:731-9. (Pubitemid 41420160)
13. Lee M, Park J. Regulation of NFAT activation: a potential therapeutic target for immunosuppression. Mol Cells 2006;22:1-7. (Pubitemid 44323038)
14. Legnani P, Kornbluth A. Newer therapies for inflammatory bowel disease. Curr Treat Options Gastroenterol 2004;7:161-7. (Pubitemid 38899303)
15. Liu WC, Slusarchyk DS, Astle G, Trejo WH, Brown WE, Meyers E. Ionomycin, a new polyether antibiotic. J Antibiot Tokyo 1978;31:815-9. (Pubitemid 9040535)
16. Loh C, Shaw KT, Carew J, Viola JP, Luo C, Perrino BA, et al. Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J Biol Chem 1996;271:10884-91. (Pubitemid 26145827)
17. Malek TR, Bayer AL. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 2004;4:665-74. (Pubitemid 39223073)
18. Matsukura T, Tanaka H. Applicability of zinc complex of L-carnosine for medical use. Biochem Mosc 2000;65:817-23.
19. Miskin JE, Abrams CC, Goatley LC, Dixon LK. A viral mechanism for inhibition of the cellular phosphatase calcineurin. Science 1998;281:562-5.
20. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803. (Pubitemid 19057602)
21. Nielsen OH, Vainer B, Rask-Madsen J. Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine. Aliment Pharmacol Ther 2001;15:1699-708. (Pubitemid 33001133)
22. Odashima M, Otaka M, Jin M, Wada I, Horikawa Y, Matsuhashi T, et al. Zinc L-carnosine protects colonic mucosal injury through induction of heat shock protein 72 and suppression of NF-kappaB activation. Life Sci 2006;79:2245-50. (Pubitemid 44666062)
23. Ohkawara T, Takeda H, Kato K, Miyashita K, Kato M, Iwanaga T, et al. Polaprezinc (N-(3-aminopropionyl)-L-histidinato zinc) ameliorates dextran sulfate sodium-induced colitis in mice. Scand J Gastroenterol 2005;40:1321-7. (Pubitemid 41658731)
24. Paspatis GA, Karamanolis DG, Vasilakaki T, Zizi A, Xourgias V, Elemenoglou I, et al. Proliferative activity in colonic adenomas as a predictor of metachronous adenomas as assessed by proliferating cell nuclear antigen immunohistochemistry. Am J Gastroenterol 1995;90:597-602.
25. Passfall J, Distler A, Riecken EO, Zeitz M. Onset of ulcerative colitis in a cyclosporin-treated patient. Lancet 1991;338:9.
26. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29. (Pubitemid 34851835)
27. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997;15:707-47. (Pubitemid 27169297)
28. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-61. (Pubitemid 23320289)
29. Shibasaki F, Price ER, Milan D, McKeon F. Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature 1996;382:370-3. (Pubitemid 26260467)
30. Shih TC, Hsieh SY, Hsieh YY, Chen TC, Yeh CY, Lin CJ, et al. Aberrant activation of nuclear factor of activated T cell 2 in lamina propria mononuclear cells in ulcerative colitis. World J Gastroenterol 2008;14:1759-67.
31. Siegel CA, Sands BE. Review article: practical management of inflammatory bowel disease patients taking immunomodulators. Aliment Pharmacol Ther 2005;22:1-16. (Pubitemid 40943869)
32. Stange EF, Fleig WE, Rehklau E, Ditschuneit H. Cyclosporin A treatment in inflammatory bowel disease. Dig Dis Sci 1989;34:1387-92. (Pubitemid 19247395)
33. Takahashi K, Akaishi E, Abe Y, Ishikawa R, Tanaka S, Hosaka K, et al. Zinc inhibits calcineurin activity in vitro by competing with nickel. Biochem Biophys Res Commun 2003;307:64-8. (Pubitemid 36808536)
34. Tamaki H, Nakase H, Matsuura M, Inoue S, Mikami S, Ueno S, et al. The effect of tacrolimus (FK-506) on Japanese patients with refractory Crohn's disease. J Gastroenterol 2008;43:774-9.
35. Tanaka S, Akaishi E, Hosaka K, Okamura S, Kubohara Y. Zinc ions suppress mitogen-activated interleukin-2 production in Jurkat cells. Biochem Biophys Res Commun 2005;335:162-7. (Pubitemid 41350776)
36. Wallace JL, MacNaughton WK, Morris GP, Beck PL. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 1989;96:29-36. (Pubitemid 19046263)
37. Weigmann B, Lehr HA, Yancopoulos G, Valenzuela D, Murphy A, Stevens S, et al. The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis. J Exp Med 2008;205:2099-110.
38. Yoshikawa T, Yamaguchi T, Yoshida N, Yamamoto H, Kitazumi S, Takahashi S, et al. Effect of Z-103 on TNB-induced colitis in rats. Digestion 1997;58:464-8. (Pubitemid 27445615)